Tanios Bekaii-Saab, MD,

Medical Director, Gastrointestinal Oncology and Assistant Professor of Medicine and Pharmacology, Ohio State University Medical Center
Dr Bekaii-Saab's research interests include experimental therapeutics/translational research focused on molecularly-targeted and immune-mediated therapies in gastrointestinal (GI) cancers, and more specifically pancreas and biliary cancers. He is the principal investigator on numerous clinical trials, including studies supported through research grants from the National Cancer Institute (NCI) and the National Comprehensive Cancer Network (NCCN).